טוען...
Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
The prevalence and economic burden of atrial fibrillation (AF) are predicted to more than double over the next few decades. In addition to anticoagulation and treatment of concomitant cardiovascular conditions, early and standardized rhythm control therapy reduces cardiovascular outcomes as compared...
שמור ב:
| הוצא לאור ב: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208749/ https://ncbi.nlm.nih.gov/pubmed/33982075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvab153 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|